Minimal hepatic encephalopathy: Natural history, impact on daily functioning, and role of treatment

Indian Journal of Gastroenterology

Volumn 22, Issue SUPPL. 2, 2003, Pages

  Duseja, A ^a   Dhiman, R K ^a   Saraswat, V A ^b   Chawla, Y ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cirrhosis; Hepatic encephalopathy; Neurophysiological tests; Psychometric tests; Subclinical hepatic encephalopathy

Indexed keywords

BRANCHED CHAIN AMINO ACID; CASEIN; FLUMAZENIL; LACTITOL; LACTULOSE; ORNITHINE ASPARTATE;

ALERTNESS; CLINICAL TRIAL; CONFERENCE PAPER; DAILY LIFE ACTIVITY; DISEASE COURSE; DRIVING ABILITY; DRUG EFFECT; DRUG EFFICACY; ESOPHAGUS VARICES; HEPATIC ENCEPHALOPATHY; HUMAN; INTERPERSONAL COMMUNICATION; LIVER CIRRHOSIS; MINIMAL HEPATIC ENCEPHALOPATHY; NEUROPSYCHOLOGICAL TEST; PROGNOSIS; PROTEIN RESTRICTION; PSYCHOMETRY; SLEEP; SOCIAL INTERACTION; STOMACH VARICES; SURVIVAL;

ACTIVITIES OF DAILY LIVING; ELECTROPHYSIOLOGY; HEPATIC ENCEPHALOPATHY; HUMANS; PSYCHOMETRICS;

EID: 1442314216     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Gitlin N. Subclinical portal systemic encephalopathy. Am J Gastroenterol 1988;82:8-11.
2. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT, and the members of the Working Party. Hepatic encephalopathy - Definition, Nomenclature, Diagnosis and Quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-21.
3. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986;3:75-82.
4. Gilberstad SJ, Gilberstadt H, Zieve L. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980;140:519-21.
5. Dhiman RK, Saraswat VA, Verma M, Naik SR. Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol 1995;10:14-23.
6. Hartman IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000;95:2029-34.
7. Yen CL, Liaw YF. Somatosensory evoked potentials and number connection test in the detection of hepatic encephalopathy. Hepatogastroenterology 1990;37:332-4.
8. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001;16:531-5.
9. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essinkbot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45-9.
10. Schomerus M, Hamster W, Blunck H, Reinhard U, Mayer K, Doll W. Latent portasystemic encephalopathy. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981;26:622-30.
11. Horsmans Y, Solbreux PM, Daenens C, Desager JP, Geubel AP. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy. Aliment Pharmacol Ther 1997;11:165-70.
12. Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Gortelmeyer R, et al. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo controlled double blind study. J Hepatol 1998;28:856-64.
13. Dhiman RK, Sawhney IMS, Chawla YK, Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci 2000;45:1549-52.
14. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96:2718-23.
15. Amodio P, Piccolo FD, Marchetti P, Angeli P, Iemmolo R, Caregaro L, et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by number connection test and computerized psychometric tests. Hepatology 1999;29:1662-7.
16. Cordoba J, Cabrera J, Lataif L, Pener P, Zee P, Blei AT. High prevalence of sleep disturbances in cirrhosis. Hepatology 1998;27:339-45.
17. Blei AT, Cordoba J. Subclinical encephalopathy. Dig Dis 1996;14(Suppl 1):2-11.
18. Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995;10:239-48.
19. Srivastava A, Mehta R, Rothke SP, Rademaker AW, Blei AT. Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance. J Hepatol 1994;21:1023-8.
20. Quero JC, De Bruijn I, Hartmann IJ, Schalm SW. Does subclinical hepatic encephalopathy affect quality of life? (Abstract)., Gastroenterology 1995;108:1151A.
21. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001;16:37-41
22. Bruijn KM DE, Blendis LM, Zilm DH, Carlen PL, Anderson GH. Effect of dietary protein manipulations in subclinical portal-systemic encephalopathy. Gut 1983;24:53-60.
23. Egberts EH, Schomerus H, Hamster W, Jurgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled cross-over study. Gastroenterology 1985;88:887-95.
24. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R, et al. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double blind study. Hepatology 1997;25:1351-60.
25. Amodio P, Marchetti P, Del Piccolo F, Beghi A, Comacchio F, Carraro P, et al. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double blind placebo controlled study. Clin Physiol 1997;17:533-9.
26. Vasconez C, Elizalde JI, Llach J, Gines A, de la Rosa C, Fernandez RM, et al. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. J Hepatol 1999;30:260-4.
27. Watanabe A, Sakai T, Sato S, Imai F, Ohto M, Arakawa Y, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997;26:1410-4.